CARRI', MARIA TERESA
 Distribuzione geografica
Continente #
NA - Nord America 41.248
EU - Europa 3.139
AS - Asia 1.090
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 10
OC - Oceania 8
Totale 45.507
Nazione #
US - Stati Uniti d'America 41.206
DE - Germania 636
UA - Ucraina 587
SG - Singapore 562
PL - Polonia 390
FR - Francia 337
CN - Cina 329
IE - Irlanda 318
RU - Federazione Russa 191
IT - Italia 186
SE - Svezia 157
GB - Regno Unito 147
KR - Corea 121
FI - Finlandia 120
CA - Canada 39
ID - Indonesia 17
BE - Belgio 16
JP - Giappone 16
NL - Olanda 16
EU - Europa 11
IN - India 10
CZ - Repubblica Ceca 9
VN - Vietnam 9
AU - Australia 8
UZ - Uzbekistan 8
DK - Danimarca 6
IL - Israele 6
RO - Romania 6
AT - Austria 5
BR - Brasile 5
CL - Cile 5
GR - Grecia 4
KG - Kirghizistan 4
CH - Svizzera 3
ES - Italia 2
HU - Ungheria 2
IR - Iran 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BD - Bangladesh 1
CR - Costa Rica 1
DM - Dominica 1
MY - Malesia 1
PH - Filippine 1
SA - Arabia Saudita 1
TR - Turchia 1
TW - Taiwan 1
VI - Stati Uniti Isole Vergini 1
Totale 45.507
Città #
Woodbridge 12.914
Wilmington 10.780
Houston 10.277
Fairfield 1.315
Ann Arbor 1.004
Ashburn 600
Jacksonville 543
Seattle 496
Singapore 496
Chandler 484
Cambridge 440
Kraków 389
Dublin 310
Dearborn 290
Medford 258
Beijing 153
Lawrence 122
Santa Clara 106
Mülheim 94
New York 73
San Diego 64
Rome 60
Menlo Park 55
Norwalk 45
Falls Church 38
Detroit 37
Mountain View 37
Zhengzhou 35
Toronto 32
University Park 31
Boardman 29
Milan 27
Moscow 27
Redwood City 23
Saint Petersburg 22
London 21
Verona 18
Jakarta 17
Brussels 16
Munich 16
Nürnberg 16
Phoenix 16
Nanjing 15
Hefei 14
Kunming 14
Guangzhou 13
San Mateo 11
Chicago 10
Jinan 10
Brno 9
Los Angeles 9
Shanghai 9
Hounslow 8
Dong Ket 7
Indiana 6
Palo Alto 6
Groningen 5
Hangzhou 5
Hebei 5
Helsinki 5
San Francisco 5
Jena 4
Redmond 4
Shenyang 4
Wuhan 4
Yellow Springs 4
Clearwater 3
Frascati 3
Melbourne 3
Nottingham 3
Seoul 3
Sezze 3
Sury-le-Comtal 3
Tappahannock 3
Vienna 3
Wandsworth 3
Amsterdam 2
Auburn Hills 2
Barzanò 2
Cassano Magnago 2
Changsha 2
Chengdu 2
Chongqing 2
Delhi 2
Frankfurt am Main 2
Fuzhou 2
Hanoi 2
Islington 2
Kemerovo 2
Kilburn 2
La Canada Flintridge 2
Langenargen 2
Leawood 2
Lugo 2
Monmouth Junction 2
Ningbo 2
Nuremberg 2
Ottawa 2
Paris 2
Pune 2
Totale 42.090
Nome #
S -Nitrosoglutathione Reductase Plays Opposite Roles in SH-SY5Y Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis 478
Mutation of Lys-120 and Lys-134 drastically reduces the catalytic rate of Cu,Zn superoxide dismutase 474
Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis 460
Inactivation of cytochrome c oxidase by mutant SOD1s in mouse motoneuronal NSC-34 cells is independent from copper availability but is because of nitric oxide 455
Regulation of CU, ZNSOD by metals in S-Cereivisiae and Zea-Mays 453
Three-dimensional structure of Xenopus laevis Cu,Zn superoxide dismutase b determined by X-ray crystallography at 1.5 A resolution 445
Structural insights into the multi-determinant aggregation of TDP-43 in motor neuron-like cells 440
Resistance to striatal dopamine depletion induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice expressing human mutant Cu,Zn superoxide dismutase 439
Developmental expression of Cu,Zn superoxide dismutase in Xenopus. Constant level of the enzyme in oogenesis and embryogenesis 438
Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals 437
Differential role of superoxide and glutathione in S-nitrosoglutathione-mediated apoptosis: a rationale for mild forms of familial amyotrophic lateral sclerosis associated with less active Cu,Zn superoxide dismutase mutants 434
Dynamic NAD(P)H post-synaptic autofluorescence signals for the assessment of mitochondrial function in a neurodegenerative disease: monitoring the primary motor cortex of G93A mice, an amyotrophic lateral sclerosis model 431
Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications 429
Effect of Lys->Arg mutation on the thermal stability of Cu,Zn superoxide dismutase: Influence on the monomer-dimer equilibrium 428
Copper depletion increases the mitochondrial-associated SOD1 in neuronal cells 428
2-DE and MALDI-TOF-MS for a comparative analysis of proteins expressed in different cellular models of amyotrophic lateral sclerosis 427
Xenopus laevis U1 snRNA genes: characterisation of transcriptionally active genes reveals major and minor repeated gene families 426
Apoptotic mechanisms in mutant LRRK2-mediated cell death 424
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 424
A study of the dual role of copper in superoxide dismutase as antioxidant and pro-oxidant in cellular models of amyotrophic lateral sclerosis 422
An electron microscope study of chromosomal DNA replication in different eukaryotic systems 416
The unfolded protein response in models of human mutant G93A amyotrophic lateral sclerosis 416
Activation and induction by copper of Cu/Zn superoxide dismutase in Saccharomyces cerevisiae. Presence of an inactive proenzyme in anaerobic yeast 415
Xenopus laevis Cu,Zn superoxide dismutase B cDNA sequence 415
Role of zinc-coordination and of the glutathione redox couple in the redox susceptibility of human transcription factor Sp1 414
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 412
Superoxide dismutase 1 modulates expression of transferrin receptor 411
Purification and characterization of Ag,Zn-superoxide dismutase from Saccharomyces cerevisiae exposed to silver 411
Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress 411
LRRK2 affects vesicle trafficking, neurotransmitter extracellular level and membrane receptor localization 411
Minocycline for patients with ALS. 410
The relationship between chromosomal origins of replication and the nuclear matrix during the cell cycle 409
ALS: focus on purinergic signalling 408
Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice 408
SIRT3 and mitochondrial metabolism in neurodegenerative diseases 407
Amyotrophic lateral sclerosis: mechanisms and countermeasures 406
Voltage-activated sodium currents in a cell line expressing a Cu,Zn superoxide dismutase typical of familial ALS 406
Nuclear accumulation of mRNAs underlies G4C2-repeat-induced translational repression in a cellular model of C9orf72 ALS 405
Mitochondrial damage modulates alternative splicing in neuronal cells: implications for neurodegeneration 404
The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis. 404
Impaired copper binding by the H46R mutant of human Cu,Zn superoxide dismutase, involved in amyotrophic lateral sclerosis 401
Chromosome length and DNA loop size during early embryonic development of Xenopus laevis 401
Apoptosome inactivation rescues proneural and neural cells from neurodegeneration 401
Lessons from models of SOD1-linked familial ALS 400
Continuous monitoring of ascorbate transport through neuroblastoma cells with a ruthenium oxide hexacyanoferrate modified microelectrode 400
Expression of a Cu, Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of neuroblastoma cells to infectious injury 398
Differential role of superoxide and glutathione in S-nitrosoglutathione-mediated apoptosis: A rationale for mild forms of familial amyotrophic lateral sclerosis associated with less active Cu,Zn superoxide dismutase mutants 398
Primary structure from amino acid and cDNA sequences of two Cu,Zn superoxide dismutase variants from Xenopus laevis 398
Temperature-dependent protein folding in vivo--lower growth temperature increases yield of two genetic variants of Xenopus laevis Cu,Zn superoxide dismutase in Escherichia coli 398
Amyotrophic Lateral Sclerosis: New Insights into Underlying Molecular Mechanisms and Opportunities for Therapeutic Intervention 398
Glutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity 397
Pathways to mitochondrial dysfunction in ALS pathogenesis 397
Evidence for co-regulation of Cu,Zn superoxide dismutase and metallothionein gene expression in yeast through transcriptional control by copper via the ACE 1 factor 396
Interaction of cisplatin with human superoxide dismutase 396
Metal uptake of recombinant cambialistic superoxide dismutase from Propionitbacterium shermanii is affected by growth conditions of host Escherichia coli cells 395
Pur-alpha functionally interacts with FUS carrying ALS-associated mutations 395
Bcl2-A1 interacts with pro-caspase-3: Implications for amyotrophic lateral sclerosis. 394
SOD1 and mitochondria in ALS: a dangerous liaison. 394
Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways 394
Glutaredoxin 1 is a major player in copper metabolism in neuroblastoma cells 393
Cu,Zn-superoxide dismutase-dependent apoptosis induced by nitric oxide in neuronal cells 392
Copper-dependent oxidative stress and neurodegeneration 391
Mitochondria and ALS: Implications from novel genes and pathways 391
Neuronal RNA-binding proteins in health and disease 391
Which TDP-43 aggregates are toxic in ALS? 391
Oxidative inactivation of calcineurin by Cu,Zn superoxide dismutase G93A, a mutant typical of familial amyotrophic lateral sclerosis 390
Cystatin B and SOD1: protein–protein interaction and possible relation to neurodegeneration 389
Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials 388
The role of metals and their effect on oxidative stress in amyotrophic lateral sclerosis 387
Activity of protein phosphatase calcineurin is decreased in sporadic and familial amyotrophic lateral sclerosispatients 386
Cell death in amyotrophic lateral sclerosis: interplay between neuronal and glial cells 386
Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease 385
Oligomerization of mutant SOD1 in mitochondria of motoneuronal cells drives mitochondrial damage and cell toxicity 384
Mitochondrial dynamism and the pathogenesis of Amyotrophic Lateral Sclerosis 382
Oxidative stress and mitochondrial damage: Importance in non-SOD1 ALS 381
Calcineurin activity is regulated both by redox compounds and by mutant familial amyotrophic lateral sclerosis-superoxide dismutase 380
The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis 379
Altered gene expression, mitochondrial damage and oxidative stress: converging routes in motor neuron degeneration 379
Cysteine modifications in the pathogenesis of ALS 378
Apoptosome-deficient cells lose cytochrome c through proteasomal degradation but survive by autophagy-dependent glycolysis 373
A relationship between replicon size and supercoiled loop domains in the eukaryotic genome 372
Increase of Cu,Zn-superoxide dismutase activity during differentiation of human K562 cells involves activation by copper of a constantly expressed copper-deficient protein 369
Inflammatory cytokines increase mitochondrial damage in motoneuronal cells expressing mutant SOD1 368
Cysteine 111 affects aggregation and cytotoxicity of mutant Cu,Zn-superoxide dismutase associated with familial amyotrophic lateral sclerosis 368
Copper-dependent oxidative stress, alteration of signal transduction and neurodegeneration in amyotrophic lateral sclerosis 365
Mutant SOD1 and mitochondrial damage alter expression and splicing of genes controlling neuritogenesis in models of neurodegeneration 364
The Cu,Zn superoxide dismutase isoenzymes of Xenopus laevis: purification, identification of a heterodimer and differential heat sensitivity 364
Oxidative modulation of nuclear factor-kappaB in human cells expressing mutant fALS-typical superoxide dismutases 364
Apaf1 mediates apoptosis and mitochondrial damage induced by mutant human SOD1s typical of familial amyotrophic lateral sclerosis 364
Mitochondrial dysfunction in ALS 361
Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells 361
The sinister side of Italian soccer 361
Oxidative stress and mitochondrial damage in the pathogenesis of ALS: New perspectives 360
Mislocalised FUS mutants stall spliceosomal snRNPs in the cytoplasm. 358
Mitochondrial redox signalling by p66Shc mediates ALS-like disease through Rac1 inactivation 355
Philanthropy: ice-bucket challenge should jolt funding 355
Crystal structure of the cyanide-inhibited Xenopus laevis Cu,Zn superoxide dismutase at 98 K 348
Increased SOD1 association with chromatin, DNA damage, p53 activation, and apoptosis in a cellular model of SOD1-linked ALS 346
The intriguing case of motor neuron disease: ALS and SMA come closer 342
Targets in ALS: designing multidrug therapies 340
Totale 39.823
Categoria #
all - tutte 82.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.191


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.236 0 0 0 0 0 1.354 1.074 1.116 1.182 911 732 867
2020/20216.616 760 821 766 830 667 681 814 671 164 130 253 59
2021/20221.265 55 143 71 58 34 115 70 51 100 105 78 385
2022/20231.376 150 104 25 212 101 315 115 61 130 6 128 29
2023/2024347 61 6 17 8 36 111 10 20 4 2 1 71
2024/20251.114 92 533 250 128 52 59 0 0 0 0 0 0
Totale 45.894